Caris Life Sciences secured $310 million in growth capital that will be used to expand the molecular science company’s presence in precision medicine in oncology.
https://www.pharmalive.com/wp-content/uploads/2020/10/Caris-Life-Sciences-Secures-310-Million-to-Advance-Precision-Medicine-Toolset-BioSpace-10-27-20.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-10-27 11:28:132020-10-27 12:40:01Caris Life Sciences Secures $310 Million to Advance Precision Medicine Toolset